DE
| Investor | Type | Est. change | Change | Δ Own | Date | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Essex Investment Management Co LLC
· Exited
Change
−346K
Δ Own
−100.0%
Date
Q1 2026
|
Essex Investment Management Co LLC | Exited· Q1 2026 | – | −346K | −100.0% | Q1 2026 | |||||
|
J. Goldman & Co LP
· Reduced
Change
−298K
Date
Q1 2026
|
J. Goldman & Co LP | Reduced· Q1 2026 | – | −298K | – | Q1 2026 | |||||
|
Tang Capital Management LLC
· Reduced
Change
−245K
Date
Q1 2026
|
Tang Capital Management LLC | Reduced· Q1 2026 | – | −245K | – | Q1 2026 | |||||
|
Legato Capital Management LLC
· Exited
Change
−112K
Δ Own
−100.0%
Date
Q1 2026
|
Legato Capital Management LLC | Exited· Q1 2026 | – | −112K | −100.0% | Q1 2026 | |||||
|
Informed Momentum Co LLC
· Exited
Change
−89K
Δ Own
−100.0%
Date
Q1 2026
|
Informed Momentum Co LLC | Exited· Q1 2026 | – | −89K | −100.0% | Q1 2026 | |||||
|
Millennium Management LLC
· Reduced
Change
−75K
Date
Q1 2026
|
Millennium Management LLC | Reduced· Q1 2026 | – | −75K | – | Q1 2026 | |||||
|
Citadel Advisors LLC
· Exited
Change
−69K
Δ Own
−100.0%
Date
Q1 2026
|
Citadel Advisors LLC | Exited· Q1 2026 | – | −69K | −100.0% | Q1 2026 | |||||
|
Geneos Wealth Management Inc.
· Exited
Change
−63K
Δ Own
−100.0%
Date
Q1 2026
|
Geneos Wealth Management Inc. | Exited· Q1 2026 | – | −63K | −100.0% | Q1 2026 | |||||
|
AQR Capital Management LLC
· Exited
Change
−51K
Δ Own
−100.0%
Date
Q1 2026
|
AQR Capital Management LLC | Exited· Q1 2026 | – | −51K | −100.0% | Q1 2026 | |||||
|
Creative Planning
· Exited
Change
−51K
Δ Own
−100.0%
Date
Q1 2026
|
Creative Planning | Exited· Q1 2026 | – | −51K | −100.0% | Q1 2026 | |||||
|
BNP Paribas Financial Markets
· Reduced
Change
−23K
Date
Q1 2026
|
BNP Paribas Financial Markets | Reduced· Q1 2026 | – | −23K | – | Q1 2026 | |||||
|
Jump Financial, LLC
· Exited
Change
−20K
Δ Own
−100.0%
Date
Q1 2026
|
Jump Financial, LLC | Exited· Q1 2026 | – | −20K | −100.0% | Q1 2026 | |||||
|
Marshall Wace, LLP
· Exited
Change
−19K
Δ Own
−100.0%
Date
Q1 2026
|
Marshall Wace, LLP | Exited· Q1 2026 | – | −19K | −100.0% | Q1 2026 | |||||
|
Occudo Quantitative Strategies LP
· Exited
Change
−19K
Δ Own
−100.0%
Date
Q1 2026
|
Occudo Quantitative Strategies LP | Exited· Q1 2026 | – | −19K | −100.0% | Q1 2026 | |||||
|
Barclays PLC
· Reduced
Change
−18K
Date
Q1 2026
|
Barclays PLC | Reduced· Q1 2026 | – | −18K | – | Q1 2026 | |||||
| Insider | Title | Type | Price | Qty | Value | Owned | ΔOwn | Trade date | Filed date | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Toledano Miranda Jayne
· Director
Grant (A)
50K
|
Toledano Miranda Jayne | Director | Grant (A) | – | 50K | – | 169K | +42.2% | Jul 1, 2026 | Jul 2, 2026 | |||||||||
|
Smith Justin Adam
· Director
Grant (A)
50K
|
Smith Justin Adam | Director | Grant (A) | – | 50K | – | 232K | +27.5% | Jul 1, 2026 | Jul 2, 2026 | |||||||||
|
Herskowitz Neil
· Director
Grant (A)
50K
|
Herskowitz Neil | Director | Grant (A) | – | 50K | – | 169K | +42.2% | Jul 1, 2026 | Jul 2, 2026 | |||||||||
|
Toledano Miranda Jayne
· Director
Grant (A)
10K
|
Toledano Miranda Jayne | Director | Grant (A) | – | 10K | – | 119K | +9.2% | Jun 25, 2026 | Jun 29, 2026 | |||||||||
|
Smith Justin Adam
· Director
Grant (A)
10K
|
Smith Justin Adam | Director | Grant (A) | – | 10K | – | 182K | +5.8% | Jun 25, 2026 | Jun 26, 2026 | |||||||||
|
Herskowitz Neil
· Director
Grant (A)
10K
|
Herskowitz Neil | Director | Grant (A) | – | 10K | – | 119K | +9.2% | Jun 25, 2026 | Jun 26, 2026 | |||||||||
|
Pearce Michael Cooper
· Director
Grant (A)
10K
|
Pearce Michael Cooper | Director | Grant (A) | – | 10K | – | 67K | +17.5% | Jun 25, 2026 | Jun 26, 2026 | |||||||||
|
Rosenwald Lindsay A. Md
· Director
Grant (A)
10K
|
Rosenwald Lindsay A. Md | Director | Grant (A) | – | 10K | – | 221K | +4.7% | Jun 25, 2026 | Jun 26, 2026 | |||||||||
|
Alloush Ramsey
· Officer
2 operations
110K
|
Alloush Ramsey | Officer | 2 operations | – | 110K | – | 63K | – | Apr 22, 2026 | Apr 24, 2026 | |||||||||
|
Benesch Joseph
· CFO
2 operations
71K
|
Benesch Joseph | CFO | 2 operations | – | 71K | – | 42K | – | Apr 22, 2026 | Apr 24, 2026 | |||||||||
|
Maraoui Claude
· Director
2 operations
132K
|
Maraoui Claude | Director | 2 operations | – | 132K | – | 83K | – | Apr 22, 2026 | Apr 24, 2026 | |||||||||
|
Maraoui Claude
· Director, Officer
2 operations
0
|
Maraoui Claude | Director, Officer | 2 operations | $0.07 | 0 | – | 0 | – | Aug 25, 2025 | Aug 26, 2025 | |||||||||
|
Maraoui Claude
· Director, Officer
Tax withholding or exercise payment (F)
-$81K
|
Maraoui Claude | Director, Officer | Tax withholding or exercise payment (F) | $7.47 | -11K | -$81K | 2.4M | – | Aug 25, 2025 | Aug 26, 2025 | |||||||||
|
Rosenwald Lindsay A. Md
· Director
Grant (A)
50K
|
Rosenwald Lindsay A. Md | Director | Grant (A) | – | 50K | – | 211K | – | Aug 5, 2025 | Aug 7, 2025 | |||||||||
|
Smith Justin Adam
· Director
Grant (A)
20K
|
Smith Justin Adam | Director | Grant (A) | – | 20K | – | 172K | – | Aug 5, 2025 | Aug 7, 2025 | |||||||||
74 reporting institutions disclosed DERM position changes in the Q1 2026 snapshot.
For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.
An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.
Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.
Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.
A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.